All stock lists
Resmed Inc (New York Stock Exchange:RMD)
US · Delayed Price · Currency is USD
Also listed: 0KW4.LHealthcare · Medical - Instruments & Supplies
252.80-0.06 (-0.02%)
Insider Score
––Not scored
RMD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RMD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.46 B | 1.43 B | 1.42 B | 1.34 B | 1.35 B | 1.29 B |
| Revenue Growth (YoY) | 8.58 % | 10.81 % | 10.98 % | 9.07 % | 10.20 % | 7.92 % |
| Cost of Revenue | 602.43 M | 540.43 M | 538.15 M | 514.76 M | 527.92 M | 525.33 M |
| Gross Profit | 861.22 M | 890.98 M | 884.66 M | 820.82 M | 820.07 M | 766.41 M |
| SG&A Expense | 296.28 M | 279.80 M | 278.40 M | 259.19 M | 265.13 M | 245.30 M |
| R&D Expense | 105.72 M | 94.27 M | 90.97 M | 87.32 M | 86.44 M | 83.94 M |
| Operating Expenses | 412.51 M | 391.17 M | 387.06 M | 374.28 M | 365.53 M | 340.14 M |
| Operating Income | 448.71 M | 499.81 M | 497.60 M | 446.54 M | 454.54 M | 426.27 M |
| Pretax Income | 474.16 M | 502.31 M | 496.15 M | 446.79 M | 458.05 M | 417.69 M |
| Tax Provision | 90.73 M | 103.58 M | 103.55 M | 98.26 M | 78.35 M | 52.65 M |
| Net Income | 383.43 M | 398.73 M | 392.59 M | 348.54 M | 379.70 M | 365.04 M |
| EPS (Basic) | 2.65 | 2.72 | 2.69 | 2.38 | 2.59 | 2.49 |
| EPS (Diluted) | 2.64 | 2.71 | 2.68 | 2.37 | 2.58 | 2.48 |
| Shares Outstanding | 144.71 M | 146.47 M | 146.47 M | 146.47 M | 146.47 M | 146.72 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.